Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford University. The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, aimed at exploring ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

Cancer has long been one of the most feared diseases in the world. Now, a groundbreaking development in vaccine technology ...

At close: January 23 at 4:00:02 PM EST ...